Antimetastatic intraoperative chemotherapy of human colon tumors in the livers of nude mice

Clinical Cancer Research

Volumn 6, Issue 6, 2000, Pages 2464-2468

  Rashidi, Babak ^a,b   An, Zili ^a   Sun, Fang Xian ^a   Moossa, A R ^b   Hoffman, Robert M ^a,b  

^a ANTICANCER INC   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SURVIVAL; COLON TUMOR; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LIVER RESECTION; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; LIVER; LYMPHATIC METASTASIS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; TIME FACTORS; TREATMENT OUTCOME; TUMOR CELLS, CULTURED;

EID: 0034094149     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Hughes, K. S., Simon, R., Songhorabodi, S., Adson, M. A., Ilstrup, D. M., Fortner, J. G., Maclean, B. J., Foster, J. H., Daly, J. M., Fitzherbert, D., et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns recurrence. Surgery, 100: 278-284, 1986.
2. Fong, Y., Cohen, A. M., Fortner, J. G., Enker, W. E., Turnbull, A. D., Coit, D. G., Marrero, A. M., Prasad, M., Blumgart, L. H., and Brennan, M. F. Liver resection for colorectal metastases. J. Clin. Oncol., 15: 938-946, 1997.
3. Nordlinger, B., Jaeck, D., Guiguet, M., Valiant, J. C., Balladur, P., and Schaal, J. C. Surgical resection of hepatic metastases. Multicentric retrospective study by the French Association of Surgery. In: B. Nordlinger, D. Jaeck (eds.). Treatment of Hepatic Metastases of Colorectal Cancer, pp. 129-146. Berlin: Springer, 1992.
4. Muller, J. M., Schmidt, A., Strauss, J. M., and Zieren, H. U. Resection of liver metastases of colorectal carcinoma: claims and reality. Dtsch. Med. Wochenschr., 116: 681-688, 1991.
5. Fortner, J. G., Silva, J. S., Cox, E. B., Golbey, R. B., Gallowitz, H., and Maclean, B. J. Multivariate analysis of a personal series of 247 patients with liver metastases from colorectal cancer. Treatment by intrahepatic chemotherapy. Ann. Surg., 199: 317-324, 1984.
6. Hohenberger, P., Schlag, P., Schwarz, V., and Herfarth, C. Tumor recurrence and options for further treatment after resection of liver metastases in patients with colorectal cancer. J. Surg. Oncol., 44: 245-251, 1990.
7. Bozzetti, F., Doci, R., Bignami, P., Morabito, A., and Gennari, L. Patterns of failure following surgical resection of colorectal cancer liver metastases. Rationale for a multimodel approach. Ann. Surg., 205: 264-270, 1987.
8. Ekberg, H., Tranberg, K. G., Andersson, R., Lundstedt, C., Hagerstrand, I., Ranstam, J., and Bengmark, S. Determinants of survival in liver resection for colorectal secondaries. Br. J. Surg., 73: 727-731, 1986.
9. August, D. A., Sugarbaker, P. H., Ottow, R. T., Gianola, F. J., and Schneider, P. D. Hepatic resection of colorectal metastases. Influence of clinical factors and adjuvant intraperitoneal 5-FU via Tenckhoff catheter on survival. Ann. Surg., 201: 210-218, 1985.
10. Petrelli, N. J., Nambisan, R. N., Herrera, L., and Mittelman, A. Hepatic resection for isolated metastases from colorectal carcinoma. Am. J. Surg., 149: 205-209, 1985.
11. Butler, J., Attiyeh, F. F., and Daly, J. M. Hepatic resection for metastases of the colon and rectum. Surg. Gynecol. Obstet., 762: 109-113, 1996.
12. Nordlinger, B., Quilichini, M. A., Parc, M., Hannoun, L., Delva, E., and Huguet, C. Hepatic resection for colorectal liver metastases. Influence on survival of preoperative factors and surgery for recurrence in 80 patients. Ann. Surg., 205: 256-263, 1987.
13. Engstrom, P. F., Macintyre, J. M., Douglass, H. O., Jr., Muggia, F., and Mittelman, A. Combination chemotherapy of advanced colorectal cancer utilizing 5-fluorouracil, semustine, decarbazine, vincristine, and hydroxyurea. A phase III trial by the Eastern Cooperative Oncology Group (EST: 4275). Cancer, 49: 1555-1560, 1982.
14. Begos, D. G., and Ballantyne, G. H. Regional chemotherapy for colorectal liver metastases: thirty years without patients benefit. J. Surg. Oncol., 56: 139-144, 1994.
15. Lorenz, M., Muller, H. H., Schramm, H., Gassel, H. J., Rau, H. G., Ridwelski, K., Hauss, J., Stieger, R., Jauch, K. W., Bechstein, W. O., and Encke, A. Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-FU and folinic acid for liver metastases of colorectal cancer. Ann. Surg., 228: 756-762, 1998.
16. Kemeny, N., Cohen, A., Huang, Y., Shi, W., Blumgart, L., Turnbull, A., Sullivan, D., Stockman, J., and Fong, Y. Randomized study of hepatic arterial infusion (HAI) and systemic chemotherapy (SYS) versus SYS alone as adjuvant therapy after resection of hepatic metastases from colorectal cancer. Proc. Am. Soc. Clin. Oncol., 18: 263a, 1999.
17. Kemeny M. M., Adak, S., Lipstiz, S., Gray, B., Macdonald, J., and Benson, A. B. Result of the intergroup [Eastern Cooperative Oncology Group (SWOG)] prospective randomized study of surgery alone versus continuous hepatic artery infusion of FUDR and continuous systemic infusion of 5FU after hepatic resection for colorectal liver metastases. Proc. Am. Soc. Clin. Oncol., 18: 264a, 1999.
18. Patt, Y. Z. Regional hepatic arterial chemotherapy for colorectal cancer metastatic to the liver: the controversy continues. J, Clin. Oncol., 11: 815-819, 1993.
19. Kemeny, M., Daly, J., Oderman, P., Shike, M., Chun, H., Petroni, G., and Geller, N. Hepatic artery pump infusion: toxicity and results in patients with metastatic colorectal carcinoma. J. Clin. Oncol., 2: 595-600, 1984.
20. Archer, G. S., and Gray, B. N. Vascularization of small liver metastases. Br. J. Surg., 76: 545-548, 1989.
21. Elias, D., Lasser, P., Rougier, P., Nitenberg, G., Theodore, C., and Lumbroso, J. Early adjuvant intraportal chemotherapy after curative hepatectomy for colorectal liver metastases - a pilot study. Eur. J. Surg. Oncol., 13: 247-250, 1987.
22. Andersson, R., and Holmberg, A. Intraperitoneal 5-FU in the management of colorectal liver cancer. Eur. J. Surg. Oncol., 18: 152-155, 1992.
23. Markman, M. Intraperitoneal chemotherapy for malignant diseases of the gastrointestinal tract. Surg. Gynecol. Obstet., 164: 89-93, 1987.
24. Archer, S., and Gray, B. Intraperitoneal 5-FU infusion for treatment of both peritoneal and liver micrometastases. Surgery, 108: 502-507, 1990.
25. Nordlinger, B., Panis, Y., Puts, P. J., Herve, J. P., Delelo, R., and Ballet, F. Experimental model of colon cancer: recurrences after surgery alone or associated with intraperitoneal 5-FU chemotherapy. Dis. Colon Rectum, 34: 658-663, 1991.
26. Yang, T. S., Hsu, K. C., Chiang, J. M., Tang, R., Chen, J. S., Changchien, C. R., and Wang, J. Y. A simplified regime of weekly high dose 5-fluorouracil and leucovorin as a 24 hour infusion in patients with advanced colorectal carcinoma. Cancer, 85: 1925-1930, 1999.
27. Fu, X., Besterman, J. M., Monosov, A., and Hoffman, R. M. Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens. Proc. Natl. Acad. Sci. USA, 88: 9345-9349, 1991.
28. Fu, X., Guadagni, F., and Hoffman, R. M. A metastatic nude mouse model of human pancreatic cancer constructed by using histologically intact patient specimens. Proc. Natl. Acad. Sci. USA., 89: 5645-5649, 1992.
29. Hoffman, R. M. Patient-like models of human cancer in mice. Curr. Perspect. Mol. Cell. Oncol., 1: 311-326, 1992.
30. An, Z., Ping, J., Wang, X., Moossa, A. R., and Hoffman, R. M. Development of a high metastatic orthotopic model of human renal cell carcinoma in nude mice: benefits of fragment implantation compared to cell-suspension injection. Clin. Exp. Metastasis, 17: 265-270, 2000.
31. Wang, X., Fu, X., and Hoffman, R. M. A new patients-like metastatic model of human lung cancer constructed orthotopically with intact tissue via thoracotomy in immunodeficient mice. Int. J. Cancer, 51: 992-995, 1992.
32. Sun, F. X., Sasson, A., Jiang, P., An, Z., Gamagami, R., Li, L., Moossa, A. R., and Hoffman, R. M. An ultra-metastatic model of human colon cancer in nude mice. Clin. Exp. Metastasis, 17: 41-48, 1999.
33. Rashidi, B., Gamagami, R., Sasson, A., Sun, F-X., Geller, J., Moossa, A. R., and Hoffman, R. M. An orthotopic mouse model of re-metastases of human colon cancer liver metastases. Clin. Cancer Res., in press, 2000.
34. Speyer, J. L., Sugarbaker, P. H., Collins, J. M., Dedrick, R. L., Klecker, R. W., and Myers, C. E. Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans. Cancer Res., 41: 1916-1922, 1981.
35. Gyves, J. Pharmacology of intraperitoneal infusion of 5-fluorouracil and mitomycin-C. Semin. Oncol., 12: 29-32, 1985.
36. Lukas, G., Brindle, S., and Greengard, P. The route of absorption of intraperitoneally administrated compounds. J. Pharmacol. Exp. Ther., 178: 562-566, 1971.
37. Speyer, J. L., Collins, J. M., Dedrick, R. L., Brennan, M. F., Buckpitt, A. R., Lender, H., DeVita, V. T., Jr., and Myers, C. E. Phase I and pharmacological studies of 5-fluorouracil administrated intraperitoneally. Cancer Res., 40: 567-572, 1980.
38. Niederhuber, J. E., and Ensminger, W. D. Surgical consideration in the management of hepatic neoplasia. Semin. Oncol., 10: 135-147, 1983.
39. Breedis, C., and Young, G. The blood supply of neoplasm in the liver. Am. J. Pathol., 30: 969-977, 1954.
40. Bismuth, H., Adam, R., Levi, F., Farabos, C., Waechter, F., Castaing, D., Majno, P., and Engerran, L. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann. Surg., 224: 509-522, 1996.
41. Gutman, M., Singh, R. K., Price, J. E., Fan, D., and Fidler, I. Accelerated growth of human colon cancer cells in nude mice undergoing liver regeneration. Invasion Metastasis, 14: 362-371, 1994-95.
42. Mizutani, J., Hiraoka, T., Yamashita, R., and Miyauchi, Y. Promotion of hepatic metastases by liver resection in the rat. Br. J. Cancer, 65: 794-797, 1992.
43. Mahteme, H., Larsson, B. S., Sundin, A., and Graf, W. 5-FU uptake in liver metastases after intravenous and intraperitoneal administration: an autoradiographic study in the rat. Anticancer Res., 18: 943-949, 1998.